VRC07-523LS trials for HIV

All VRC07-523LS trials · All HIV trials

Phase breakdown

Recruiting trials studying VRC07-523LS for HIV

• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 36 locations
• RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
  NCT06484335 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• The Tatelo Plus Study
  NCT06508749 · Phase: Phase 1, Phase 2 · Ages: 24 Weeks to 25 Years · Sex: All (male and female) · 2 locations
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · 46 locations

Common questions

How many trials study VRC07-523LS for HIV?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.